COMED – Trademark Portfolio

Entity Type: 98

COMED holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include RONI, COMED, CUROL, MIOBOL, and WINMIX.

Boeleberg 2

B-3730 Bilzen-Hoeselt

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CUROL
CUROL
Registered 2021
MIOBOL
MIOBOL
Registered 2021
LISOCUR +
LISOCUR +
Registered 2021
RONI
RONI
Registered 2021
WINMIX
WINMIX
Registered 2021
FERTIBOL
FERTIBOL
Registered 2021
COMED
COMED
Registered 2021

Trademark Classifications

COMED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does COMED have?

COMED has 8 U.S. trademarks filed with the USPTO. Of these, 8 registered.

What trademark classes does COMED file in?

COMED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are COMED's most well-known trademarks?

COMED's registered trademark portfolio includes well-known marks such as RONI, COMED, CUROL, MIOBOL, and WINMIX. These are among 8 currently registered trademarks in the portfolio.

What is COMED's trademark registration success rate?

COMED has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.